Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0393754 (
HSA
)
2,996
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We demonstrate here that the transient receptor potential melastatin subfamily channel,
TRPM4
, controls migration of bone marrow-derived mast cells (BMMCs), triggered by dinitrophenylated human serum albumin (DNP-HSA) or stem cell factor (SCF). Wild-type BMMCs migrate after stimulation with DNP-
HSA
or SCF whereas both stimuli do not induce migration in BMMCs derived from
TRPM4
knockout mice (trpm4(-/-)). Mast cell migration is a Ca(2+)-dependent process, and
TRPM4
likely controls this process by setting the intracellular Ca(2+) level upon cell stimulation. Cell migration depends on filamentous actin (F-actin) rearrangement, since pretreatment with cytochalasin B, an inhibitor of F-actin formation, prevented both DNP-
HSA
- and SCF-induced migration in wild-type BMMC. Immunocytochemical experiments using fluorescence-conjugated phalloidin demonstrate a reduced level of F-actin formation in DNP-
HSA
-stimulated BMMCs from trpm4(-/-) mice. Thus, our results suggest that
TRPM4
is critically involved in migration of BMMCs by regulation of Ca(2+)-dependent actin cytoskeleton rearrangements.
...
PMID:TRPM4 regulates migration of mast cells in mice. 1904 67